Sándor Németh is a partner at Szecskay Attorneys at Law who focuses on Life-sciences with an emphasis on Biotech, corporate M&A transactions, and, his signature area of expertise, wealth management and trusts.
Sándor has solid experience in private clientele, including succession planning, wealth management and family businesses, which is an area in growing demand on the legal market place.
As the Chair of the Legal Committee of the Hungarian Biotechnology Association, Sándor is certainly the name to go to for Start-ups and innovative SMEs in the Life-sciences sector. Within this field, Sándor has a particular interest in R&D, with a specific emphasis on clinical trials.
He is a lecturer on International Corporate Law at Pázmány Péter University.
He is fluent in English and German and conversational in Russian.
"The lawyers are quick and talented."
Chambers Europe, 2023, Life Sciences
"We have always been able to speak to the legal counsels from Szecskay as if they were business partners and they always understood the business matters at hand and it has given us comfort."
Chambers Global, 2023, Corporate/ M&A
"A highly professional team with specialists covering certain key areas. During an M&A process, they bring in specialist lawyers for these key areas. So it is a one-stop-shop for high quality specialist advice."
Legal500 2023, Commercial, Corporate and M&A
"They are an independent Hungarian law firm with vast international experience and connections. They have real market experience and their legal solutions prove a very good understanding of business. You will hardly meet a team that is so responsive, aligned and puts their whole hearts in it to make a deal perfect."
Legal500 2022, Commercial, Corporate and M&A
"The team has a very high standard, is hand-on, knowledgeable and very good at time management, vey approachable and responsive."
Legal500 2021, Commercial, Corporate and M&A
One client describes Sándor Németh as "very pragmatic and knowledgeable," and adds that "he is one of the leading lawyers in this field."
Chambers Europe, 2020, Life Sciences
Other professional memberships: